PsyScale brings together psychiatry's most trusted rating scales in a free, open-access platform.
Start a scaleThe scales included in PsyScale are widely considered gold standards in clinical psychiatry. They have been validated by the scientific community for their sensitivity and specificity. That said, their use is not without debate — not all clinicians rely on standardized scales in their practice, and some instruments are more contested than others. PsyScale does not take a position on this: its sole purpose is to bring these questionnaires together in a single, freely accessible place.
No scale has been modified. The questions, scoring methods, and interpretations are those commonly used in clinical settings and in the scientific literature. Full references and source links for each instrument are available on the Methodology page.
Some scales are designed to be administered by a clinician (e.g., MADRS, HDRS-17, YMRS), while others can be used as self-report instruments (e.g., PHQ-9, GAD-7, MDI). Each scale card indicates whether it is clinician-rated or self-report. These scales do not replace a clinical evaluation and do not constitute a diagnosis. PsyScale is not a medical device.
PsyScale does not store any data. No account is required, and nothing is transmitted to a server — all processing happens locally in your browser. The scales are available in English and in French.
Select the scale you wish to complete.
PsyScale is designed to bring clarity and efficiency to clinical practice. It combines 40 validated psychiatric rating scales into one offline, private, clinician-focused tool. No cloud sync, no trackers, no subscription required.
Allison, C., Auyeung, B., & Baron-Cohen, S. (2012). Toward brief "Red Flags" for autism screening: The Short Autism Spectrum Quotient and the Short Quantitative Checklist in 1,000 cases and 3,000 controls. Journal of the American Academy of Child & Adolescent Psychiatry, 51(2), 202–212.
https://pubmed.ncbi.nlm.nih.gov/22265366/
DOI: 10.1016/j.jaac.2011.11.003
Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The Autism-Spectrum Quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17.
https://pubmed.ncbi.nlm.nih.gov/11439754/
DOI: 10.1023/a:1005653411471
Altman, E. G., Hedeker, D., Peterson, J. L., & Davis, J. M. (1997). The Altman Self-Rating Mania Scale. Biological Psychiatry, 42(10), 948-955.
https://pubmed.ncbi.nlm.nih.gov/9359982/
DOI: 10.1023/a:1005653411471
Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245-256
https://pubmed.ncbi.nlm.nih.gov/15841682/
DOI: 10.1017/s0033291704002892
Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R. and Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption II. Addiction 1993; 88:791-804.
https://pubmed.ncbi.nlm.nih.gov/8329970/
DOI: 10.1111/j.1360-0443.1993.tb02093.x
Gormally, J., Black, S., Daston, S., & Rardin, D. (1982). The assessment of binge eating severity among obese persons. Addictive Behaviors, 7(1), 47–55.
https://pubmed.ncbi.nlm.nih.gov/7080884/
DOI: 10.1016/0306-4603(82)90024-7
Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10(3), 799–812. / Overall, J. E., Hollister, L. E., & Pichot, P. (1967). "Major psychiatric disorders: A four-dimensional model." Archives of General Psychiatry, 16(2), 146–151.
https://pubmed.ncbi.nlm.nih.gov/6019329/
DOI: 10.1001/archpsyc.1967.01730200014003
Bech, P., Bolwig, T. G., Kramp, P., & Rafaelsen, O. J. (1979). The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatrica Scandinavica, 59(4), 420–430.
https://pubmed.ncbi.nlm.nih.gov/433633/
DOI: 10.1111/j.1600-0447.1979.tb04484.x
Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., & Mann, J. J. (2011). The Columbia–Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry, 168(12), 1266–1277.
https://pubmed.ncbi.nlm.nih.gov/22193671/
DOI: 10.1176/appi.ajp.2011.10111704
Ewing, J. A. (1984). Detecting alcoholism: the CAGE questionnaire. JAMA, 252(14), 1905–1907.
https://pubmed.ncbi.nlm.nih.gov/6471323/
DOI: 10.1001/jama.252.14.1905
Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: the Calgary Depression Scale. British Journal of Psychiatry, 163(Suppl 22), 39–44.
https://pubmed.ncbi.nlm.nih.gov/8110442/
DOI: 10.1192/S0007125000292581
Haro, J. M., Kamath, S. A., Ochoa, S., Novick, D., Rele, K., Fargas, A., Rodríguez, M. J., Rele, R., Orta, J., Kharbeng, A., Araya, S., Gervin, M., Alonso, J., Mavreas, V., Lavrentzou, E., Liontos, N., Gregor, K., & Jones, P. B. (2003). The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica, 107(s416), 16–23.
https://pubmed.ncbi.nlm.nih.gov/12755850/
DOI: 10.1034/j.1600-0447.107.s416.5.x
Skinner, H. A. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363–371.
https://pubmed.ncbi.nlm.nih.gov/7183189/
DOI: 10.1016/0306-4603(82)90005-3
Bernstein, E. M., & Putnam, F. W. (1986). Development, reliability, and validity of a dissociation scale. Journal of Nervous and Mental Disease, 174(12), 727–735. / Carlson, E. B., & Putnam, F. W. (1993). An update on the Dissociative Experiences Scale. Dissociation, 6(1), 16–27.
https://pubmed.ncbi.nlm.nih.gov/3783140/
DOI: 10.1097/00005053-198612000-00004
Abramowitz, J. S., Deacon, B. J., Olatunji, B. O., Wheaton, M. G., Berman, N. C., Losardo, D., Timpano, K. R., McGrath, P. B., Riemann, B. C., Adams, T., Steinberg, J. S., Hook, J. N., & Hale, L. R. (2010). Assessment of obsessive-compulsive symptom dimensions: Development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychological Assessment, 22(1), 180–198.
https://pubmed.ncbi.nlm.nih.gov/20230164/
DOI: 10.1037/a0018260
Garner, D. M., Olmsted, M. P., Bohr, Y., & Garfinkel, P. E. (1982). The eating attitudes test: psychometric features and clinical correlates. Psychological Medicine, 12(4), 871–878.
https://pubmed.ncbi.nlm.nih.gov/6961471/
DOI: 10.1017/s0033291700049163
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782–786.
https://pubmed.ncbi.nlm.nih.gov/3651732/
DOI: 10.1192/bjp.150.6.782
Johns, M. W. (1991). A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep, 14(6), 540–545.
https://pubmed.ncbi.nlm.nih.gov/1798888/
DOI: 10.1093/sleep/14.6.540
Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86(9), 1119–1127.
https://pubmed.ncbi.nlm.nih.gov/1932883/
DOI: 10.1111/j.1360-0443.1991.tb01879.x
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
https://pubmed.ncbi.nlm.nih.gov/16717171/
DOI: 10.1001/archinte.166.10.1092
Yesavage, J. A., Brink, T. L., Rose, T. L., et al. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17(1), 37–49.
https://pubmed.ncbi.nlm.nih.gov/7183759/
DOI: 10.1016/0022-3956(82)90033-4
Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1), 50–55.
https://pubmed.ncbi.nlm.nih.gov/13638508/
DOI: 10.1111/j.2044-8341.1959.tb00467.x
Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T. D., Skeppar, P., Vieta, E., & Scott, J. (2005). The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders, 88(2), 217–233.
https://pubmed.ncbi.nlm.nih.gov/16125784/
DOI: 10.1016/j.jad.2005.05.011
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56–62.
https://pubmed.ncbi.nlm.nih.gov/14399272/
DOI: 10.1136/jnnp.23.1.56
Weiss, D. S., & Marmar, C. R. (1997). The Impact of Event Scale – Revised. In J. P. Wilson & T. M. Keane (Eds.), Assessing Psychological Trauma and PTSD (pp. 399–411). Guilford Press.
ISBN: 978-1-572-30162-7
Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307.
https://pubmed.ncbi.nlm.nih.gov/11438246/
DOI: 10.1016/s1389-9457(00)00065-4
Montgomery, S. A., & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134(4), 382–389.
https://pubmed.ncbi.nlm.nih.gov/444788/
DOI: 10.1192/bjp.134.4.382
Selzer, M. L. (1971). The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. American Journal of Psychiatry, 127(12), 1653–1658.
https://pubmed.ncbi.nlm.nih.gov/5565851/
DOI: 10.1176/ajp.127.12.1653
Bech, P., Rasmussen, N.-A., Olsen, L. R., Noerholm, V., & Abildgaard, W. (2001). The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. Journal of Affective Disorders, 66(2-3), 159–164.
https://pubmed.ncbi.nlm.nih.gov/11578668/
DOI: 10.1016/s0165-0327(00)00309-8
Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Jr, Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., Russell, J. M., Sachs, G. S., & Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875.
https://pubmed.ncbi.nlm.nih.gov/11058490/
DOI: 10.1176/appi.ajp.157.11.1873
Zanarini, M. C., Vujanovic, A. A., Parachini, E. A., Boulanger, J. L., Frankenburg, F. R., & Hennen, J. (2003). A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). Journal of Personality Disorders, 17(6), 568–573.
https://pubmed.ncbi.nlm.nih.gov/14744082/
DOI: 10.1521/pedi.17.6.568.25355
Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002). The Obsessive-Compulsive Inventory-Revised: development and validation. Psychological Assessment, 14(4), 485–496.
https://pubmed.ncbi.nlm.nih.gov/12501574/
DOI: 10.1037/1040-3590.14.4.485
Prins, A., Bovin, M. J., Smolenski, D. J., Marx, B. P., Kimerling, R., Jenkins-Guarnieri, M. A., Kaloupek, D. G., Schnurr, P. P., Kaiser, A. P., Leyva, Y. E., & Tiet, Q. Q. (2016). The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample. Journal of General Internal Medicine, 31(10), 1206–1211.
https://pubmed.ncbi.nlm.nih.gov/27170304/
DOI: 10.1007/s11606-016-3703-5
Weathers, F.W., Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., & Schnurr, P.P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD.
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997). Multicenter collaborative Panic Disorder Severity Scale. American Journal of Psychiatry, 154(11), 1571-1575.
Houck, P. R., Spiegel, D. A., Shear, M. K., & Rucci, P. (2002). Reliability of the self-report version of the Panic Disorder Severity Scale. Depression and Anxiety, 15(4), 183–185.
https://pubmed.ncbi.nlm.nih.gov/9356566/
DOI: 10.1176/ajp.154.11.1571
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.
https://pmc.ncbi.nlm.nih.gov/articles/PMC1495268/
DOI: 10.1046/j.1525-1497.2001.016009606.x
Osman, A., Bagge, C. L., Gutierrez, P. M., et al. (2001). The Suicidal Behaviors Questionnaire-Revised (SBQ-R): validation with clinical and nonclinical samples. Assessment, 8(4), 443–454.
https://pubmed.ncbi.nlm.nih.gov/11785588/
DOI: 10.1177/107319110100800409
Morgan, J. F., Reid, F., & Lacey, J. H. (1999). The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ, 319(7223), 1467–1468.
https://pubmed.ncbi.nlm.nih.gov/10582927/
DOI: 10.1136/bmj.319.7223.1467
Carlson, E. (2001). Psychometric study of a brief screen for PTSD: Assessing the impact of multiple traumatic events. Assessment, 8, 431-441.
https://pubmed.ncbi.nlm.nih.gov/11785587/
DOI: 10.1177/107319110100800408
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133(5), 429–435.
https://pubmed.ncbi.nlm.nih.gov/728692/
DOI: 10.1192/bjp.133.5.429
The table below documents every scale currently implemented in PsyScale — including its scoring method, reference period, and the interpretation thresholds used in the app. These thresholds are sourced from original validation studies or widely-cited clinical conventions; when ambiguity exists, the most conservative or commonly adopted cutoff is applied and annotated in the Notes column.
If you spot an error in a threshold, a scoring rule, or any other detail — or if a newer validation study establishes cutoffs with improved sensitivity and specificity — please reach out. The goal is for this reference to stay accurate and up to date.
| Scale | Full name | Source Citation | PubMed link | DOI |
|---|---|---|---|---|
| AQ-10 | Autism Spectrum Quotient (10-item) | Allison, C., Auyeung, B., & Baron-Cohen, S. (2012). Toward brief "Red Flags" for autism screening: The Short Autism Spectrum Quotient and the Short Quantitative Checklist in 1,000 cases and 3,000 controls. Journal of the American Academy of Child & Adolescent Psychiatry, 51(2), 202–212. | https://pubmed.ncbi.nlm.nih.gov/22265366/ | DOI: 10.1016/j.jaac.2011.11.003 |
| AQ-50 | Autism Spectrum Quotient (50-item) | Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001). The Autism-Spectrum Quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. Journal of Autism and Developmental Disorders, 31(1), 5–17. | https://pubmed.ncbi.nlm.nih.gov/11439754/ | DOI: 10.1023/a:1005653411471 |
| ASRM | The Altman Self-Rating Mania Scale | Altman, E. G., Hedeker, D., Peterson, J. L., & Davis, J. M. (1997). The Altman Self-Rating Mania Scale. Biological Psychiatry, 42(10), 948-955. | https://pubmed.ncbi.nlm.nih.gov/9359982/ | DOI: 10.1016/S0006-3223(96)00548-3 |
| ASRS | Adult ADHD Self-Report Scale | Kessler, R.C., Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., Howes, M.J., Jin, R., Secnik, K., Spencer, T., Ustun, T.B., Walters, E.E. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychological Medicine, 35(2), 245-256 | https://pubmed.ncbi.nlm.nih.gov/15841682/ | DOI: 10.1017/s0033291704002892 |
| AUDIT | Alcohol Use Disorders Identification Test | Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R. and Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption II. Addiction 1993; 88:791-804. | https://pubmed.ncbi.nlm.nih.gov/8329970/ | DOI: 10.1111/j.1360-0443.1993.tb02093.x |
| BES | Binge Eating Scale | Gormally, J., Black, S., Daston, S., & Rardin, D. (1982). The assessment of binge eating severity among obese persons. Addictive Behaviors, 7(1), 47–55. | https://pubmed.ncbi.nlm.nih.gov/7080884/ | DOI: 10.1016/0306-4603(82)90024-7 |
| BPRS-18 | Brief Psychiatric Rating Scale (18-item) | Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10(3), 799–812. / Overall, J. E., Hollister, L. E., & Pichot, P. (1967). "Major psychiatric disorders: A four-dimensional model." Archives of General Psychiatry, 16(2), 146–151. | https://pubmed.ncbi.nlm.nih.gov/6019329/ | DOI: 10.1001/archpsyc.1967.01730200014003 |
| BRMRS | Bech-Rafaelsen Mania Rating Scale | Bech, P., Bolwig, T. G., Kramp, P., & Rafaelsen, O. J. (1979). The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatrica Scandinavica, 59(4), 420–430. | https://pubmed.ncbi.nlm.nih.gov/433633/ | DOI: 10.1111/j.1600-0447.1979.tb04484.x |
| C-SSRS | Columbia Suicide Severity Rating Scale | Posner, K., Brown, G. K., Stanley, B., Brent, D. A., Yershova, K. V., Oquendo, M. A., Currier, G. W., Melvin, G. A., Greenhill, L., Shen, S., & Mann, J. J. (2011). The Columbia–Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. American Journal of Psychiatry, 168(12), 1266–1277. | https://pubmed.ncbi.nlm.nih.gov/22193671/ | DOI: 10.1176/appi.ajp.2011.10111704 |
| CAGE | CAGE Alcohol Questionnaire | Ewing, J. A. (1984). Detecting alcoholism: the CAGE questionnaire. JAMA, 252(14), 1905–1907. | https://pubmed.ncbi.nlm.nih.gov/6471323/ | DOI: 10.1001/jama.252.14.1905 |
| CDSS | Calgary Depression Scale for Schizophrenia | Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: the Calgary Depression Scale. British Journal of Psychiatry, 163(Suppl 22), 39–44. | https://pubmed.ncbi.nlm.nih.gov/8110442/ | DOI: 10.1192/S0007125000292581 |
| CGI-SCH | Clinical Global Impression – Schizophrenia | Haro, J. M., Kamath, S. A., Ochoa, S., Novick, D., Rele, K., Fargas, A., Rodríguez, M. J., Rele, R., Orta, J., Kharbeng, A., Araya, S., Gervin, M., Alonso, J., Mavreas, V., Lavrentzou, E., Liontos, N., Gregor, K., & Jones, P. B. (2003). The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica, 107(s416), 16–23. | https://pubmed.ncbi.nlm.nih.gov/12755850/ | DOI: 10.1034/j.1600-0447.107.s416.5.x |
| DAST-10 | Drug Abuse Screening Test (10-item) | Skinner, H. A. (1982). The Drug Abuse Screening Test. Addictive Behaviors, 7(4), 363–371. | https://pubmed.ncbi.nlm.nih.gov/7183189/ | DOI: 10.1016/0306-4603(82)90005-3 |
| DES-II | Dissociative Experiences Scale | Bernstein, E. M., & Putnam, F. W. (1986). Development, reliability, and validity of a dissociation scale. Journal of Nervous and Mental Disease, 174(12), 727–735. / Carlson, E. B., & Putnam, F. W. (1993). An update on the Dissociative Experiences Scale. Dissociation, 6(1), 16–27. | https://pubmed.ncbi.nlm.nih.gov/3783140/ | DOI: 10.1097/00005053-198612000-00004 |
| DOCS | Dimensional Obsessive-Compulsive Scale | Abramowitz, J. S., Deacon, B. J., Olatunji, B. O., Wheaton, M. G., Berman, N. C., Losardo, D., Timpano, K. R., McGrath, P. B., Riemann, B. C., Adams, T., Steinberg, J. S., Hook, J. N., & Hale, L. R. (2010). Assessment of obsessive-compulsive symptom dimensions: Development and evaluation of the Dimensional Obsessive-Compulsive Scale. Psychological Assessment, 22(1), 180–198. | https://pubmed.ncbi.nlm.nih.gov/20230164/ | DOI: 10.1037/a0018260 |
| EAT-26 | Eating Attitudes Test (26-item) | Garner, D. M., Olmsted, M. P., Bohr, Y., & Garfinkel, P. E. (1982). The eating attitudes test: psychometric features and clinical correlates. Psychological Medicine, 12(4), 871–878. | https://pubmed.ncbi.nlm.nih.gov/6961471/ | DOI: 10.1017/s0033291700049163 |
| EPDS | Edinburgh Postnatal Depression Scale | Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150, 782–786. | https://pubmed.ncbi.nlm.nih.gov/3651732/ | DOI: 10.1192/bjp.150.6.782 |
| ESS | Epworth Sleepiness Scale | Johns, M. W. (1991). A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep, 14(6), 540–545. | https://pubmed.ncbi.nlm.nih.gov/1798888/ | DOI: 10.1093/sleep/14.6.540 |
| FTND | Fagerström Test for Nicotine Dependence | Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86(9), 1119–1127. | https://pubmed.ncbi.nlm.nih.gov/1932883/ | DOI: 10.1111/j.1360-0443.1991.tb01879.x |
| GAD-7 | Generalized Anxiety Disorder (7-item) | Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. | https://pubmed.ncbi.nlm.nih.gov/16717171/ | DOI: 10.1001/archinte.166.10.1092 |
| GDS-30 | Geriatric Depression Scale (30-item) | Yesavage, J. A., Brink, T. L., Rose, T. L., et al. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17(1), 37–49. | https://pubmed.ncbi.nlm.nih.gov/7183759/ | DOI: 10.1016/0022-3956(82)90033-4 |
| HAM-A | Hamilton Anxiety Rating Scale | Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32(1), 50–55. | https://pubmed.ncbi.nlm.nih.gov/13638508/ | DOI: 10.1111/j.2044-8341.1959.tb00467.x |
| HCL-32 | Hypomania Checklist (32-item) | Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T. D., Skeppar, P., Vieta, E., & Scott, J. (2005). The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. Journal of Affective Disorders, 88(2), 217–233. | https://pubmed.ncbi.nlm.nih.gov/16125784/ | DOI: 10.1016/j.jad.2005.05.011 |
| HDRS-17 | Hamilton Depression Rating Scale (17-item) | Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23(1), 56–62. | https://pubmed.ncbi.nlm.nih.gov/14399272/ | DOI: 10.1136/jnnp.23.1.56 |
| IES-R | Impact of Event Scale - Revised | Weiss, D. S., & Marmar, C. R. (1997). The Impact of Event Scale – Revised. In J. P. Wilson & T. M. Keane (Eds.), Assessing Psychological Trauma and PTSD (pp. 399–411). Guilford Press. | None (book). ISBN: 978-1-572-30162-7 | None (book). ISBN: 978-1-572-30162-7 |
| ISI | Insomnia Severity Index | Bastien, C. H., Vallières, A., & Morin, C. M. (2001). Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2(4), 297–307. | https://pubmed.ncbi.nlm.nih.gov/11438246/ | DOI: 10.1016/s1389-9457(00)00065-4 |
| MADRS | Montgomery-Åsberg Depression Rating Scale | Montgomery, S. A., & Åsberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134(4), 382–389. | https://pubmed.ncbi.nlm.nih.gov/444788/ | DOI: 10.1192/bjp.134.4.382 |
| MAST | Michigan Alcoholism Screening Test | Selzer, M. L. (1971). The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. American Journal of Psychiatry, 127(12), 1653–1658. | https://pubmed.ncbi.nlm.nih.gov/5565851/ | DOI: 10.1176/ajp.127.12.1653 |
| MDI | Major Depression Inventory | Bech, P., Rasmussen, N.-A., Olsen, L. R., Noerholm, V., & Abildgaard, W. (2001). The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. Journal of Affective Disorders, 66(2-3), 159–164. | https://pubmed.ncbi.nlm.nih.gov/11578668/ | DOI: 10.1016/s0165-0327(00)00309-8 |
| MDQ | Mood Disorder Questionnaire | Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E., Jr, Lewis, L., McElroy, S. L., Post, R. M., Rapport, D. J., Russell, J. M., Sachs, G. S., & Zajecka, J. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. The American Journal of Psychiatry, 157(11), 1873–1875. | https://pubmed.ncbi.nlm.nih.gov/11058490/ | DOI: 10.1176/appi.ajp.157.11.1873 |
| MSI-BPD | McLean Screening Instrument for BPD | Zanarini, M. C., Vujanovic, A. A., Parachini, E. A., Boulanger, J. L., Frankenburg, F. R., & Hennen, J. (2003). A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). Journal of Personality Disorders, 17(6), 568–573. | https://pubmed.ncbi.nlm.nih.gov/14744082/ | DOI: 10.1521/pedi.17.6.568.25355 |
| OCI-R | Obsessive-Compulsive Inventory – Revised | Foa, E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, G., & Salkovskis, P. M. (2002). The Obsessive-Compulsive Inventory-Revised: development and validation. Psychological Assessment, 14(4), 485–496. | https://pubmed.ncbi.nlm.nih.gov/12501574/ | DOI: 10.1037/1040-3590.14.4.485 |
| PC-PTSD-5 | Primary care PTSD Screen for DSM-5 | Prins, A., Bovin, M. J., Smolenski, D. J., Marx, B. P., Kimerling, R., Jenkins-Guarnieri, M. A., Kaloupek, D. G., Schnurr, P. P., Kaiser, A. P., Leyva, Y. E., & Tiet, Q. Q. (2016). The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample. Journal of General Internal Medicine, 31(10), 1206–1211. | https://pubmed.ncbi.nlm.nih.gov/27170304/ | DOI: 10.1007/s11606-016-3703-5 |
| PCL-5 | PTSD Checklist for DSM-5 | Weathers, F.W., Litz, B.T., Keane, T.M., Palmieri, P.A., Marx, B.P., & Schnurr, P.P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov. | None (www.ptsd.va.gov). | None (www.ptsd.va.gov). |
| PDSS-SR | Panic Disorder Severity Scale | Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997). Multicenter collaborative Panic Disorder Severity Scale. American Journal of Psychiatry, 154(11), 1571-1575. Key secondary publication (self-report version): Houck, P. R., Spiegel, D. A., Shear, M. K., & Rucci, P. (2002). Reliability of the self-report version of the Panic Disorder Severity Scale. Depression and Anxiety, 15(4), 183–185. | https://pubmed.ncbi.nlm.nih.gov/9356566/ | DOI: 10.1176/ajp.154.11.1571 |
| PHQ-9 | Patient Health Questionnaire (9-item) | Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. | https://pmc.ncbi.nlm.nih.gov/articles/PMC1495268/ | DOI: 10.1046/j.1525-1497.2001.016009606.x |
| SBQ-R | Suicidal Behaviors Questionnaire-Revised | Osman, A., Bagge, C. L., Gutierrez, P. M., et al. (2001). The Suicidal Behaviors Questionnaire-Revised (SBQ-R): validation with clinical and nonclinical samples. Assessment, 8(4), 443–454. | https://pubmed.ncbi.nlm.nih.gov/11785588/ | DOI: 10.1177/107319110100800409 |
| SCOFF | Sick, Control, One, Fat, Food | Morgan, J. F., Reid, F., & Lacey, J. H. (1999). The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ, 319(7223), 1467–1468. | https://pubmed.ncbi.nlm.nih.gov/10582927/ | DOI: 10.1136/bmj.319.7223.1467 |
| SPTSS | Screen for Posttraumatic Stress Symptoms | Carlson, E. (2001). Psychometric study of a brief screen for PTSD: Assessing the impact of multiple traumatic events. Assessment, 8, 431-441. | https://pubmed.ncbi.nlm.nih.gov/11785587/ | DOI: 10.1177/107319110100800408 |
| YMRS | Young Mania Rating Scale | Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry, 133(5), 429–435. | https://pubmed.ncbi.nlm.nih.gov/728692/ | DOI: 10.1192/bjp.133.5.429 |
Please use this form to report a technical issue, share your suggestions or if you have any questions.
PsyScale is a free, open-access project. By supporting us, you are directly funding the hosting and technical costs required to keep this platform running.
DonatePsyScale is a digital tool that faithfully reproduces established, peer-reviewed psychiatric rating scales and questionnaires. It does not create, modify, or reinterpret any clinical instrument. It functions solely as a distributor and digital interface for instruments that are already published, validated, and freely used in clinical practice worldwide.
PsyScale computes scores strictly according to the original scoring instructions specified in the primary validation studies. Where multiple scoring conventions exist in the literature, PsyScale applies the most conservative or most widely cited cutoff and documents the choice in the Methodology section.
PsyScale does not generate diagnoses, clinical recommendations, treatment suggestions, or prognoses. It does not apply any proprietary algorithm, artificial intelligence, machine learning, or statistical model to the data entered by the user. It is a calculator and a presentation layer — nothing more.
PsyScale is not a medical device. It has not been certified, cleared, or approved under any medical device regulatory framework, including but not limited to:
PsyScale is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. It is not intended to replace, supplement, or override the professional judgment of any qualified healthcare provider.
Users should not rely on PsyScale as a medical device, and should not make any clinical, therapeutic, or diagnostic decision based solely on PsyScale output without independent clinical assessment.
PsyScale is intended for use as a clinical support tool by qualified healthcare professionals — including licensed physicians, psychiatrists, psychologists, and other credentialed practitioners operating within the scope of their professional authorization. It may also be used by individuals for informational and self-screening purposes; however, no self-assessment using PsyScale should be considered a substitute for a professional evaluation.
The scores and severity interpretations displayed by the application are derived from standardized psychometric instruments and are provided strictly for informational and reference purposes. They do not constitute a medical opinion, a diagnosis, a clinical recommendation, or a prescription.
Neither Liminal Pictures, nor its founder, nor any contributor to the development or maintenance of PsyScale, shall be held liable — under any legal theory (contract, tort, strict liability, negligence, or otherwise) — for any direct, indirect, incidental, consequential, special, exemplary, or punitive damages arising from or in connection with:
By using PsyScale, the user expressly acknowledges that all clinical responsibility for patient care rests solely and entirely with the treating practitioner, and that neither Liminal Pictures nor its founder assumes any duty of care toward any patient or end-user.
Healthcare professionals using PsyScale in a clinical context are solely responsible for:
PsyScale is not a substitute for clinical training, clinical supervision, or continuing professional education.
We collect personal information only when you fill out the contact form. The information collected may include your name, email address, and message. This data is transmitted directly by email to the founder and is not stored in any database. In accordance with the GDPR, you have the right to request access to, rectification, or deletion of your personal data by contacting us at the above address.
All data is stored in the browser's local storage and can be cleared from the browser's settings.
The PsyScale website uses only session cookies necessary for the proper functioning of the site. These are temporary and deleted when you close your browser. We do not use any tracking cookies, advertising cookies, or analytics cookies. No cookie data is shared with third parties.
If you believe any content found on this site or in the application infringes on your copyrights, please send notice to liminal.pictures.prod@gmail.com and provide the following information, as specified by 17 USC §512(c):
This Legal Notice and any dispute arising from the use of PsyScale or this website are governed by French law. In the event of a dispute and failing an amicable resolution, the matter will be brought before the competent French courts.
Liminal Pictures reserves the right to update this legal information at any time. Users are encouraged to review this page periodically. Continued use of PsyScale after any modification constitutes acceptance of the updated terms.
Last updated: June 2026
Track mood, symptoms, habits, medications — and let patterns emerge naturally over time.
Mu. is designed for simplicity and transparency.
No paywall. No trackers. No unnecessary features.
Tap the + button to log an event. You can select as many events as you like — only the ones you've chosen to track will appear in the list.
If you chose to track your mood, a colored bar appears on the home screen. Tap it to log a score on a scale of 0 to 10. You can log mood multiple times in a day — each entry is timestamped and listed separately. Tap any mood entry to expand it and edit its time or add a note. The daily average is shown in the mood bar summary.
Each logged event appears as a row under the selected day. Tap an entry to expand it: you can set a start time, an end time, and add a short note. The same event can be logged more than once on the same day. To delete an entry, expand it and tap the trash icon.
The calendar shows a colored dot for each day that has data. Swipe left or right between months. Tap any day to see its entries below, or to log new ones.
Tap the chart icon to explore your data. Switch between Events and Mood views, and use the period selector (Week, Month, Year, All) to change the time range. Swipe left or right to navigate between periods. The Events view shows a heatmap — one row per event, one column per time unit. A filled cell means the event occurred; a number inside means it occurred more than once that day. The Mood view shows a chart of your average mood over time on a fixed 0–10 scale.
Go to Settings → Manage events to add, remove, or reorder the events you track. You can also add medications (with a custom name) and free-text custom events.
Go to Settings → Reminders to enable daily notifications prompting you to log your mood. You can set up to five reminders at different times of day. Reminders can be turned on or off at any time.
Go to Settings → Export data to download your history as a CSV or as a PDF report. The PDF includes a mood chart and an event heatmap. You can choose the time period and which events to include.
If you have an Apple Watch, Mu. lets you log events and your mood directly from your wrist. Data syncs automatically with your iPhone.
Three complication styles are available: a circular one showing today's event count and mood, and two rectangular ones — one for the mood bar, one for the last event logged today.
Mu. is designed with your privacy in mind. All data you enter — including events and mood scores — is stored exclusively on your device and, if iCloud is enabled, in your personal iCloud account. No data is ever transmitted to our servers or shared with third parties.
We do not collect analytics, usage data, advertising identifiers, or any personally identifiable information. We have no access to your data.
Mu. does not use third-party SDKs, trackers, or advertising networks. The app functions entirely offline.
You retain full control over your data at all times.
To delete all your data: on Android, go to Settings → Apps → Mu. → App info → Storage → Clear storage. On iOS, uninstall the App.
This action is permanent and cannot be undone. It will remove all local data from your device.
A question, a suggestion, or a bug to report? Send a message.
Name: Louise Gib
Email: liminal.pictures.prod@gmail.com
LWS (Ligne Web Services)
10 Rue Penthièvre, 75008 Paris, France
www.lws.fr
All elements of this website, including but not limited to texts, images, photographs, videos, logos, icons, sounds, and other graphic or audiovisual content, are the exclusive property of Louise Gib. Any reproduction, representation, modification, publication, or adaptation of all or part of the elements of the site, regardless of the means or method used, is prohibited without prior written authorization.
This Legal Notice is governed by French law. In the event of a dispute and failing an amicable resolution, the matter will be brought before the competent French courts.
We collect personal information only when you fill out the contact form on our website. The information collected may include your name, email address, and message.
The information collected is used solely to respond to your inquiries. We do not share your data with third parties, except as required by law or for hosting purposes (LWS, France).
The data is not stored in a database. It is transmitted directly by email to liminal.pictures.prod@gmail.com.
In accordance with the GDPR, you have the right to request access to your personal data, to rectify or delete it. Contact us at liminal.pictures.prod@gmail.com.
We use only session cookies necessary for the proper functioning of the site. These are temporary and deleted when you close your browser. We do not use tracking cookies.